Effect of Food Intake on the Pharmacokinetics of the Selective Progesterone Receptor Modulator Vilaprisan: A Randomized Clinical Study in Healthy Postmenopausal Women

por Schultze‐Mosgau, Marcus‐Hillert, Kaiser, Andreas, Zollmann, Frank S.
Publicado 2020

Pharmacokinetics and Safety of the Novel Selective Progesterone Receptor Modulator Vilaprisan in Participants With Renal Impairment

por Schultze‐Mosgau, Marcus‐Hillert, Lasseter, Kenneth C., Marbury, Thomas, Loewen, Stephanie, Riecke, Kai
Publicado 2020

Clinical Pharmacokinetics and Pharmacodynamics of the Selective Progesterone Receptor Modulator Vilaprisan: A Comprehensive Overview

por Schultze-Mosgau, Marcus-Hillert, Ploeger, Bart A., Frei, Matthias, Höchel, Joachim, Rottmann, Antje
Publicado 2021

Effect of hepatic impairment on the pharmacokinetics of vilaprisan: An open‐label, single‐dose, parallel‐group study

por Chattopadhyay, Niladri, Riecke, Kai, Ligges, Sandra, Zimmermann, Torsten, Halabi, Atef, Schultze‐Mosgau, Marcus‐Hillert
Publicado 2019

Assessment of the safe and efficacious dose of the selective progesterone receptor modulator vilaprisan for the treatment of patients with uterine fibroids by exposure–response mod...

por Sutter, Gabriele, Frei, Matthias, Schultze‐Mosgau, Marcus‐Hillert, Petersdorf, Kathrin, Seitz, Christian, Ploeger, Bart A.
Publicado 2021

Effect of the Novel Selective Progesterone Receptor Modulator Vilaprisan on Ovarian Activity in Healthy Women

por Schütt, Barbara, Schultze‐Mosgau, Marcus‐Hillert, Draeger, Corinna, Chang, Xinying, Löwen, Stephanie, Kaiser, Andreas, Rohde, Beate
Publicado 2017

Characterization of the Pharmacokinetics of Vilaprisan: Bioavailability, Excretion, Biotransformation, and Drug–Drug Interaction Potential

por Schultze-Mosgau, Marcus-Hillert, Höchel, Joachim, Prien, Olaf, Zimmermann, Torsten, Brooks, Ashley, Bush, Jim, Rottmann, Antje
Publicado 2018

The effects of vilaprisan on the pharmacodynamics and pharmacokinetics of a combined oral contraceptive—A randomized controlled trial

por Schultze‐Mosgau, Marcus‐Hillert, Schütt, Barbara, Draeger, Corinna, Casjens, Manuela, Loewen, Stephanie, Zimmermann, Torsten, Rohde, Beate
Publicado 2020

Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies

por Möller, Carsten, Bone, Wilhelm, Cleve, Arwed, Klar, Ulrich, Rotgeri, Andrea, Rottmann, Antje, Schultze‐Mosgau, Marcus‐Hillert, Wagenfeld, Andrea, Schwede, Wolfgang
Publicado 2018

Pharmacokinetics and Safety of the Selective Progesterone Receptor Modulator Vilaprisan in Chinese Healthy Postmenopausal Women

por Liu, Hongzhong, Jiang, Ji, Chen, Zhaozhao, Zhang, Yunhui, Li, Jinyi, Hoechel, Joachim, Rohde, Beate, Zimmermann, Torsten, Schultze‐Mosgau, Marcus‐Hillert
Publicado 2020

The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension

por Gessler, Tobias, Ghofrani, Hossein-Ardeschir, Held, Matthias, Klose, Hans, Leuchte, Hanno, Olschewski, Horst, Rosenkranz, Stephan, Fels, Lueder, Li, Na, Ren, Dawn, Kaiser, Andreas, Schultze-Mosgau, Marcus-Hillert, Müllinger, Bernhard, Rohde, Beate, Seeger, Werner
Publicado 2017